AbstractAcute exacerbation of COPD (AECOPD) is an important but occasionally overlooked parameter. COPD exacerbations are very common, affecting about 20% of COPD patients. The bacterial infection plays an important role in the exacerbation of COPD patients. Quick and accurate recognition of these patients along with aggressive and prompt intervention may be the only action that prevents frank respiratory failure.Aim of the workThe aim of this work is to clarify the role of serum procalcitonin in predicting the bacterial exacerbations of COPD patients and their needs for mechanical ventilation.Methods30 COPD patients with bacterial exacerbations, 23 stable COPD patients and 20 healthy control subjects of similar age and sex were included in...
International audienceBackground: To assess the ability of procalcitonin (PCT) to distinguish betwee...
AbstractDespite advances in antimicrobial therapy, CAP remains the seventh leading cause of death in...
Abstract The 2020 Global Initiative for Obstructive Lung Disease report indicates that the blood bio...
AbstractAcute exacerbation of COPD (AECOPD) is an important but occasionally overlooked parameter. C...
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. One of t...
AbstractBackgroundRational prescription of antibiotics in acute exacerbations of COPD (AECOPD) requi...
Background: Serum procalcitonin levels have been used as a biomarker of invasive bacterial infection...
Background: Procalcitonin (PCT) is being used as a marker of bacterial infections. Although there ar...
Background: Procalcitonin (PCT) is being used as a marker of bacterial infections. Although there ar...
Background: Differentiation of the etiologies of acute exacerbations of chronic obstructive pulmonar...
Background: Rational prescription of antibiotics in acute exacerbations of COPD (AECOPD) requires pr...
Abstract Background Antibiotics are recommended for severe acute exacerbation of chronic obstructive...
Hospitalization of acute exacerbations of chronic obstructive pulmonary disease (Ae-COPD) is a commo...
The identification of biological markers in order to assess different aspects of COPD is an area of ...
Background Antibiotics are frequently prescribed for acute exacerbations of COPD (AECOPD) even thou...
International audienceBackground: To assess the ability of procalcitonin (PCT) to distinguish betwee...
AbstractDespite advances in antimicrobial therapy, CAP remains the seventh leading cause of death in...
Abstract The 2020 Global Initiative for Obstructive Lung Disease report indicates that the blood bio...
AbstractAcute exacerbation of COPD (AECOPD) is an important but occasionally overlooked parameter. C...
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. One of t...
AbstractBackgroundRational prescription of antibiotics in acute exacerbations of COPD (AECOPD) requi...
Background: Serum procalcitonin levels have been used as a biomarker of invasive bacterial infection...
Background: Procalcitonin (PCT) is being used as a marker of bacterial infections. Although there ar...
Background: Procalcitonin (PCT) is being used as a marker of bacterial infections. Although there ar...
Background: Differentiation of the etiologies of acute exacerbations of chronic obstructive pulmonar...
Background: Rational prescription of antibiotics in acute exacerbations of COPD (AECOPD) requires pr...
Abstract Background Antibiotics are recommended for severe acute exacerbation of chronic obstructive...
Hospitalization of acute exacerbations of chronic obstructive pulmonary disease (Ae-COPD) is a commo...
The identification of biological markers in order to assess different aspects of COPD is an area of ...
Background Antibiotics are frequently prescribed for acute exacerbations of COPD (AECOPD) even thou...
International audienceBackground: To assess the ability of procalcitonin (PCT) to distinguish betwee...
AbstractDespite advances in antimicrobial therapy, CAP remains the seventh leading cause of death in...
Abstract The 2020 Global Initiative for Obstructive Lung Disease report indicates that the blood bio...